Answer
Breastfeeding is not recommended throughout elranatamab (Elrexfio) treatment and for 6 months after the last dose because a risk to the breastfed child cannot be excluded.
Sources for this answer
- ELREXFIO 40 mg/mL solution for injectionPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 10Document updated
Sources checked